Stryker: A Strong Quarter

Profit growth was robust, but analysts are waiting to see if the orthopedic implant maker can put manufacturing problems to rest

Nobody will deny that 2007 was a standout year for Stryker Corp. (SYK) -- in terms of earnings growth and its increasing cash hoard -- but some analysts are waiting for two of the company's plants to pass regulatory inspection before turning gung-ho on the stock.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.